Salvato in:
Dettagli Bibliografici
Autori principali: Zeyaul Islam, Nishant N. Vaikath, Issam Hmila, Omar M. A. El‐Agnaf, Prasanna R. Kolatkar
Natura: Artículo Open Access
Pubblicazione: Wiley 2024
Soggetti:
Accesso online:https://onlinelibrary.wiley.com/doi/10.1002/pro.4875
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
_version_ 1867017667595993088
author Zeyaul Islam
Nishant N. Vaikath
Issam Hmila
Omar M. A. El‐Agnaf
Prasanna R. Kolatkar
author_facet Zeyaul Islam
Nishant N. Vaikath
Issam Hmila
Omar M. A. El‐Agnaf
Prasanna R. Kolatkar
Zeyaul Islam
Nishant N. Vaikath
Issam Hmila
Omar M. A. El‐Agnaf
Prasanna R. Kolatkar
collection Wiley Open Access
contents Structural insights into the unique recognition module between α‐synuclein peptide and nanobody Zeyaul Islam Nishant N. Vaikath Issam Hmila Omar M. A. El‐Agnaf Prasanna R. Kolatkar Protein Science AbstractNanobodies are single‐domain fragments of antibodies with comparable specificity and affinity to antibodies. They are emerging as versatile tools in biology due to their relatively small size. Here, we report the crystal structure of a specific nanobody Nbα‐syn01, bound to a 14 amino acid long peptide of α‐synuclein (αSyn), a 140‐residue protein whose aggregation is associated with Parkinson's disease. The complex structure exhibits a unique binding pattern where the αSyn peptide replaces the N‐terminal region of nanobody. Recognition is mediated principally by extended main chain interaction of the αSyn peptide and specificity of the interaction lies in the central 48–52 region of αSyn peptide. Structure‐guided truncation of Nbα‐syn01 shows tighter binding to αSyn peptide and improved inhibition of α‐synuclein aggregation. The structure of the truncated complex was subsequently determined and was indistinguishable to full length complex as the full‐length form had no visible electron density for the N‐terminal end. These findings reveal the molecular basis for a previously unobserved binding mode for nanobody recognition of α‐synuclein, providing an explanation for the enhanced binding, and potential for an alternate framework for structure‐based protein engineering of nanobodies to develop better diagnostic and therapeutic tools. 10.1002/pro.4875 http://creativecommons.org/licenses/by-nc-nd/4.0/
doi_str_mv 10.1002/pro.4875
format Artículo Open Access
id wiley_oa_10_1002_pro_4875
institution Wiley Open Access
license_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Structural insights into the unique recognition module between α‐synuclein peptide and nanobody
Zeyaul Islam
Nishant N. Vaikath
Issam Hmila
Omar M. A. El‐Agnaf
Prasanna R. Kolatkar
Protein Science
Structural insights into the unique recognition module between α‐synuclein peptide and nanobody Zeyaul Islam Nishant N. Vaikath Issam Hmila Omar M. A. El‐Agnaf Prasanna R. Kolatkar Protein Science AbstractNanobodies are single‐domain fragments of antibodies with comparable specificity and affinity to antibodies. They are emerging as versatile tools in biology due to their relatively small size. Here, we report the crystal structure of a specific nanobody Nbα‐syn01, bound to a 14 amino acid long peptide of α‐synuclein (αSyn), a 140‐residue protein whose aggregation is associated with Parkinson's disease. The complex structure exhibits a unique binding pattern where the αSyn peptide replaces the N‐terminal region of nanobody. Recognition is mediated principally by extended main chain interaction of the αSyn peptide and specificity of the interaction lies in the central 48–52 region of αSyn peptide. Structure‐guided truncation of Nbα‐syn01 shows tighter binding to αSyn peptide and improved inhibition of α‐synuclein aggregation. The structure of the truncated complex was subsequently determined and was indistinguishable to full length complex as the full‐length form had no visible electron density for the N‐terminal end. These findings reveal the molecular basis for a previously unobserved binding mode for nanobody recognition of α‐synuclein, providing an explanation for the enhanced binding, and potential for an alternate framework for structure‐based protein engineering of nanobodies to develop better diagnostic and therapeutic tools. 10.1002/pro.4875 http://creativecommons.org/licenses/by-nc-nd/4.0/
title Structural insights into the unique recognition module between α‐synuclein peptide and nanobody
topic Protein Science
url https://onlinelibrary.wiley.com/doi/10.1002/pro.4875